Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 326.00
-5.00 (-1.51%)
Aug 10, 2026, 4:59 PM CET
Zealand Pharma Ratios and Metrics
Market cap in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 23,249 | 32,931 | 50,550 | 21,787 | 10,366 | 6,271 | |
Market Cap Growth | 5.38% | -34.86% | 132.03% | 110.17% | 65.32% | -25.92% |
Enterprise Value | 9,195 | 18,228 | 41,920 | 20,273 | 9,713 | 5,630 |
Last Close Price | 326.00 | 466.40 | 715.50 | 373.20 | 201.40 | 145.10 |
PE Ratio | 3.70 | 5.17 | - | - | - | - |
Forward PE | 26.10 | 3.95 | 38.43 | 151.81 | 115.37 | 115.37 |
PS Ratio | 2.52 | 3.57 | 806.34 | 63.56 | 99.69 | 57.77 |
PB Ratio | 1.61 | 2.22 | 5.87 | 13.68 | 12.71 | 6.76 |
P/TBV Ratio | 1.62 | 2.26 | 5.53 | 13.36 | 11.40 | 7.12 |
P/FCF Ratio | 3.68 | 5.07 | - | - | - | - |
P/OCF Ratio | 3.65 | 5.04 | - | - | - | - |
EV/Sales Ratio | 1.00 | 1.98 | 668.68 | 59.14 | 93.40 | 51.87 |
EV/EBITDA Ratio | 1.34 | 2.61 | - | - | - | - |
EV/EBIT Ratio | 1.35 | 2.62 | - | - | - | - |
EV/FCF Ratio | 1.45 | 2.80 | - | - | - | - |
Debt / Equity Ratio | 0.03 | 0.03 | 0.05 | 0.07 | 0.64 | 0.83 |
Debt / EBITDA Ratio | 0.06 | 0.06 | - | - | - | - |
Debt / FCF Ratio | 0.07 | 0.06 | - | - | - | - |
Net Debt / Equity Ratio | -0.97 | -0.99 | -1.00 | -0.95 | -0.80 | -0.69 |
Net Debt / EBITDA Ratio | -2.05 | -2.10 | 6.92 | 2.77 | 0.91 | 0.86 |
Net Debt / FCF Ratio | -2.22 | -2.26 | 9.17 | 3.47 | 0.69 | 0.52 |
Asset Turnover | 0.59 | 0.72 | 0.01 | 0.19 | 0.06 | 0.06 |
Inventory Turnover | - | 0.15 | 0.85 | 4.16 | 0 | 0.12 |
Quick Ratio | 36.40 | 23.23 | 22.87 | 6.26 | 6.82 | 4.80 |
Current Ratio | 37.17 | 23.57 | 21.14 | 6.25 | 6.73 | 5.15 |
Return on Equity (ROE) | 51.14% | 64.38% | -21.31% | -58.43% | -110.75% | -70.00% |
Return on Assets (ROA) | 47.14% | 58.95% | -22.25% | -32.75% | -46.72% | -41.17% |
Return on Invested Capital (ROIC) | 2715.12% | 13155.60% | -3901.51% | -478.02% | -375.17% | -405.40% |
Return on Capital Employed (ROCE) | 45.24% | 57.08% | -23.56% | -37.65% | -54.40% | -49.96% |
Earnings Yield | 27.51% | 19.34% | - | - | - | - |
FCF Yield | 27.20% | 19.73% | - | - | - | - |
Buyback Yield / Dilution | -4.13% | -7.70% | -17.40% | -22.49% | -7.77% | -11.73% |
Total Shareholder Return | -4.13% | -7.70% | -17.40% | -22.49% | -7.77% | -11.73% |